最高の American Society Of Nephrology ポッドキャスト (2024)

1
Comparing USRDS vs. National Death Index on Sudden Cardiac Death in Dialysis Patients 5:17

11h ago5:17

5:17

In this podcast, Dr. Shafi and Dr. Obi summarize the main findings from their study on "Comparing USRDS and National Death Index Data on Sudden Cardiac Death in US Dialysis Patients" on behalf of their colleagues.American Society of Nephrology による

1
Association of Kidney Function with SGLT2 Inhibitor Discontinuation 4:05

24d ago4:05

4:05

In this podcast, Dr. Estrella summarizes the main findings from her study on "Association of kidney function with SGLT2 inhibitor discontinuation among United States Veterans" on behalf of her colleagues.American Society of Nephrology による

1
Interview with 2024 CJASN Trainee of the Year – Second Place Awardee: Dr. Mohammad Azfar Qureshi 7:32

1M ago7:32

7:32

In this podcast, CJASN Editor-in-Chief Dr. Rhee interviewed Dr. Qureshi on the findings of his study "The Association of Intra-abdominal Adhesions with Peritoneal Dialysis Catheter-Related Complications."American Society of Nephrology による

1
Interview with 2024 CJASN Trainee of the Year – First Place Awardee: Dr. Christine Limonte 5:53

1M ago5:53

5:53

In this podcast, CJASN Editor-in-Chief Dr. Rhee interviewed Dr. Limonte on the findings of her study "Associations of Biomarkers of Tubular Injury and Inflammation with Biopsy Features in Type 1 Diabetes."American Society of Nephrology による

1
Providers' Experiences Discussing Alternatives to Kidney Replacement Therapy with Patients 5:25

2M ago5:25

5:25

In this podcast, Drs. Wong and Chotivatanapong summarize the main findings from their study on "Nephrology Providers' Experiences Discussing Care for Patients with Kidney Failure who Forgo Kidney Replacement Therapy: National Qualitative Study"American Society of Nephrology による

1
Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management 17:49

3M ago17:49

17:49

CJASN editors highlight three articles centered on the theme of CKD, including articles on SGLT2 inhibitors in CKD patients; SGLT2 inhibitors and cardiovascular death in CKD; and smartphone intervention for lifestyle and hypertension management in CKD.American Society of Nephrology による

1
Fellows' Perspectives on Parental Leave Policies and Family Planning 5:52

4M ago5:52

5:52

In this podcast, Dr. Kendrick and Dr. Dixon summarize the main findings from their study on "A National Survey of Pregnancy and Parenthood Among Nephrology Trainees: A Focus on Nephrology Fellowship" on behalf of their colleagues.American Society of Nephrology による

1
Editors' Choice Articles: Pediatric ESKD iron stores, Impact of hemodiafiltration and hemodialysis on β-2-microglobulin, and Novel instruments for dialysis modality awareness 18:11

5M ago18:11

18:11

Drs. Rhee, Roshanravan, and Nigwekar highlight three cutting-edge dialysis articles on pediatric ESKD iron store biomarkers; HDF, HD, and β-2-microglobulin kinetics; and development of a novel kidney replacement therapy awareness instrument.American Society of Nephrology による

1
Kidney Measures and Venous Thromboembolism 18:10

1y ago18:10

18:10

Dr. Zhong Zheng provides an overview of his study, "Association of Estimated Glomerular Filtration Rate and Albuminuria with Venous Thromboembolism," on behalf of his colleagues.American Society of Nephrology による

1
Participant Experience in the KPMP - Spanish Language 5:50

1y ago5:50

5:50

Drs. Angela Maria Victoria-Castro and Celia Pamela Corona-Villalobos summarize the findings from their study, "Participant Experience with Protocol Research Kidney Biopsies in the Kidney Precision Medicine Project," in Spanish.American Society of Nephrology による

1
Participant Experience in the KPMP 5:01

1y ago5:01

5:01

Drs. Angela Maria Victoria-Castro and Celia Pamela Corona-Villalobos summarize the findings from their study, "Participant Experience with Protocol Research Kidney Biopsies in the Kidney Precision Medicine Project," in English.American Society of Nephrology による

1
Resveratrol in CKD 4:24

1y ago4:24

4:24

Dr. Diana I. Jalal and Colin Gimblet discuss the findings of their study, "Effect of Resveratrol on Endothelial Function in Patients with CKD and Diabetes: A Randomized Controlled Trial," on behalf of their colleagues.American Society of Nephrology による

1
Tubular Biomarkers and Kidney Histopathology in Diabetes 3:21

1y ago3:21

3:21

Dr. Christine Limonte summarizes the main findings from her study "Associations of Biomarkers of Tubular Injury and Inflammation with Biopsy Features in Type 1 Diabetes," on behalf of her colleagues.American Society of Nephrology による

1
Metabolomics and Neurocognition 3:34

1y ago3:34

3:34

Dr. Arthur M. Lee provides an overview of the results of his study, "Circulating Metabolomic Associations with Neurocognitive Outcomes in Pediatric CKD," on behalf of his colleagues.American Society of Nephrology による

1
Interstitial Eosinophilic Aggregates Predict Kidney Failure 4:08

1y ago4:08

4:08

Dr. Hattori Koki discusses the results of his study, "Interstitial Eosinophilic Aggregates and Kidney Outcome in Patients with CKD," on behalf of his colleagues.American Society of Nephrology による

1
Nurse Practitioner Care in CKD 4:38

1y ago4:38

4:38

Dr. Matthew James, Ellen Novak, and Tayler Scory summarize the results of their study, "Nurse Practitioner Care Compared to Primary Care or Nephrologist Care in Early CKD," on behalf of their colleagues.American Society of Nephrology による

1
Cardiovascular Prevention in CKD 4:46

1y ago4:46

4:46

Dr. Reza Malekzadeh gives an overview of the results of his article "Fixed-Dose Combination Therapy for Prevention of Cardiovascular Diseases in CKD: An Individual Participant Data Meta-Analysis," on behalf of his colleagues.American Society of Nephrology による

1
C3G Ig-MPGN and Complement Rare Variants 7:26

1y ago7:26

7:26

Drs. Marie-Sophie Meuleman and Sophie Chauvet provide a summary of their study, "Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative Glomerulonephritis," on behalf of their colleagues.American Society of Nephrology による

1
An Interview with Tristan de Nattes, the Second-Place Winner of the 2023 CJASN Trainee of the Year Competition 5:48

1y ago5:48

5:48

CJASN Editor-in-Chief Rajnish Mehrotra interviews Tristan de Nattes, the 2023 CJASN Trainee of the Year second-place winner, on his article, "A Simple Molecular Tool for the Assessment of Kidney Transplant Biopsies."American Society of Nephrology による

1
An Interview with Rosa D. Wouda, the First-Place Winner of the 2023 CJASN Trainee of the Year Competition 6:02

1y ago6:02

6:02

CJASN Editor-in-Chief Rajnish Mehrotra interviews 2023 CJASN Trainee of the Year winner Rosa D. Wouda on her article, "Kaliuresis and Intracellular Uptake of Potassium with Potassium Citrate and Potassium Chloride Supplements."American Society of Nephrology による

1
HPA Axis Suppression in Nephrotic Syndrome 3:24

1y ago3:24

3:24

Dr. Rajiv Sinha discusses the findings from his study, "HPA Axis in Single- versus Divided-Dose Prednisolone for First Episode Nephrotic Syndrome: An Open Label RCT," on behalf of his colleagues.American Society of Nephrology による

1
PLA2R Antibodies and Treatment Response 4:43

1y ago4:43

4:43

Drs. Daniel Cattran and Sean Barbour summarize the main results of their study, "Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy," on behalf of their colleagues.American Society of Nephrology による

1
Dasatinib Nephrotoxicity and Pharmacokinetics 4:07

1+ y ago4:07

4:07

Drs. Benjamin Adegbite and Evren Azeloglu discuss the results of their study, "Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity," on behalf of their colleagues.American Society of Nephrology による

1
eGFRcys and eGFRcr Discrepancy 5:33

1+ y ago5:33

5:33

Dr. Morgan Grams provides an overview of the findings of her study, "Discrepancies between Cystatin C–Based and Creatinine-Based Estimated Glomerular Filtration Rates," on behalf of her colleagues.American Society of Nephrology による

1
Timing KRT in Children and Young Adults 3:13

1+ y ago3:13

3:13

Dr. Nick Larkins discusses the findings of his study, "Timing of Kidney Replacement Therapy among Children and Young Adults," on behalf of his colleagues.American Society of Nephrology による

1
COVID-19–Associated AKI 5:19

1+ y ago5:19

5:19

Dr. Farrukh M. Koraishy summarizes the results of his study, "Geographic and Temporal Trends in COVID-Associated Acute Kidney Injury in the National COVID Cohort Collaborative," on behalf of his colleagues.American Society of Nephrology による

1
Nirmatrelvir/Ritonavir in Kidney Transplant Patients 4:31

1+ y ago4:31

4:31

Mr. Pierre Giguère and Dr. Swapnil Hiremath provide an overview of their study, "Management and Outcome of COVID-19 Infection Using Nirmatrelvir/Ritonavir in Kidney Transplant Patients," on behalf of their colleagues.American Society of Nephrology による

1
ICI-Induced Kidney Adverse Events 3:18

1+ y ago3:18

3:18

Dr. Gangadharan Komala provides a summary of the results of his study, "Kidney Adverse Events Associated with Immune Checkpoint Inhibitor Therapy," on behalf of his colleagues.American Society of Nephrology による

1
Albuminuria and Outcomes with Canagliflozin 6:29

1+ y ago6:29

6:29

Dr. Hiddo J.L. Heerspink summarizes the findings of his study, "Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR," on behalf of his colleagues.American Society of Nephrology による

1
Kidney Stone Events after Kidney Transplant 4:30

1+ y ago4:30

4:30

Drs. Calyani Ganesan, Alan Pao, and John Leppert discuss the results of their study, "Kidney Stone Events after Kidney Transplant in the United States," on behalf of their colleagues.American Society of Nephrology による

1
COVID-19 or Vaccinated Patients' Kidney Biopsies 4:45

1+ y ago4:45

4:45

Drs. Maria de las Mercedes Noriega and Faeq Husain-Syed discuss the results of their study "Kidney Biopsy Findings in Patients with SARS-CoV-2 Infection or After COVID-19 Vaccination," on behalf of their colleagues.American Society of Nephrology による

1
CKD Complex Interventions: Realist Review 5:46

1+ y ago5:46

5:46

Dr. Dominic Taylor provides a summary of his study "Complex Interventions across Primary and Secondary Care to Optimize Population Kidney Health," on behalf of his colleagues.American Society of Nephrology による

1
Molecular Diagnosis of Kidney Transplant Rejection 4:04

1+ y ago4:04

4:04

Dr. Tristan de Nattes discusses the results of his study "A Simple Molecular Tool for the Assessment of Kidney Transplant Biopsies," on behalf of his colleagues.American Society of Nephrology による

1
COVID-19 in Advanced CKD 5:16

1+ y ago5:16

5:16

Mr. Jian Roushani and Dr. Peter G. Blake provide an overview of their study "Clinical Outcomes and Vaccine Effectiveness for SARS-CoV-2 Infection in People Attending Advanced CKD Clinics," on behalf of their colleagues.American Society of Nephrology による

1
Metabolomics of Ultra-Processed Food and CKD 3:53

2y ago3:53

3:53

Dr. Casey Rebholz provides a summary of the findings from the study "Metabolomic Markers of Ultra-Processed Food and Incident CKD," on behalf of her colleagues.American Society of Nephrology による

1
The ASCENT Intervention: A Randomized, Effectiveness-Implementation Trial 3:33

2y ago3:33

3:33

Drs. Rachel Patzer and Stephen Pastan discuss the results of their study "The ASCENT Intervention to Improve Access and Reduce Racial Inequalities in Kidney Waitlisting," on behalf of their colleagues.American Society of Nephrology による

1
Circulating Metabolites Associated with Albuminuria in a Hispanic/Latino Population 4:06

2y ago4:06

4:06

Dr. Nora Franceschini and Ms. Kaylia Reynolds summarize the findings of their study "Circulating Metabolites Associated with Albuminuria in a Hispanic/Latino Population," on behalf of their colleagues.American Society of Nephrology による

1
Risk Factors for Pruritus in CKD 3:28

2y ago3:28

3:28

Dr. Kendra Wulczyn discusses the results of her study "Incidence and Risk Factors for Pruritus in Patients with Nondialysis CKD," on behalf of her colleagues.American Society of Nephrology による

1
A Health Survey-Based Prediction Equation for Incident CKD 6:40

2y ago6:40

6:40

Dr. Manish Sood summarizes the findings from his study, "A Health Survey-Based Prediction Equation for Incident CKD," on behalf of his colleagues.American Society of Nephrology による

1
Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases 4:15

2y ago4:15

4:15

Dr. Killian Donovan provides an overview of the conclusions from his study "Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases," on behalf of his colleagues.American Society of Nephrology による

1
Relapse in MPO-AAV with Kidney Involvement 5:28

2y ago5:28

5:28

Drs. Fernando Fervenza, Marta Casal Moura, and Ulrich Specks discuss the results of their study, "Maintenance of Remission and Risk of Relapse in Myeloperoxidase Positive Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Renal Involvement."American Society of Nephrology による

1
An Interview with Bart J. Kramers, the First-Place Winner of the 2022 CJASN Trainee of the Year Competition 7:34

2y ago7:34

7:34

CJASN Editor-in-Chief Rajnish Mehrotra interviews 2022 CJASN Trainee of the Year winner Bart J. Kramers on his article, "Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD."American Society of Nephrology による

1
An Interview with Insa Schmidt, the Second-Place Winner of the 2022 CJASN Trainee of the Year Competition 6:37

2y ago6:37

6:37

CJASN Editor-in-Chief Rajnish Mehrotra interviews Insa Schmidt, the 2022 CJASN Trainee of the Year second-place winner, on her article, "Circulating Plasma Biomarkers in Biopsy-Confirmed Kidney Disease."American Society of Nephrology による

1
Prediction of Kidney Failure in Type 2 Diabetes 3:47

2y ago3:47

3:47

Helena Bleken Østergaard discusses the results from her study "Development and Validation of a Lifetime-Risk Model for Kidney Failure and Treatment Benefit in Type 2 Diabetes," on behalf of her colleagues.American Society of Nephrology による

1
dd-cfDNA in Pediatric Kidney Transplantation 4:04

2y ago4:04

4:04

Dr. Raja Dandamudi summarizes the results of his study "Longitudinal Evaluation of Donor-Derived Cellfree DNA in Pediatric Kidney Transplantation," on behalf of his colleagues.American Society of Nephrology による

1
Toxic Occupational Exposures and Membranous Nephropathy 3:36

2y ago3:36

3:36

Dr. Marion Cremoni discusses the findings from her study "Toxic Occupational Exposures and Membranous Nephropathy," on behalf of her colleagues.American Society of Nephrology による

1
Work Functioning among Kidney Transplant Recipients 4:40

2y ago4:40

4:40

Dr. Tim Knobbe summarizes the results of his study "Employment Status and Work Functioning among Kidney Transplant Recipients," on behalf of his colleagues.American Society of Nephrology による

1
POCUS Training in Nephrology Fellowship 3:54

2+ y ago3:54

3:54

Drs. Catherine Moore, Charles O'Neill, and Daniel Ross discuss the findings from their study, "Point-of-Care Ultrasound Training during Nephrology Fellowship," on behalf of their colleagues.American Society of Nephrology による

1
Urine Uromodulin and Kidney Fibrosis 3:46

2+ y ago3:46

3:46

Drs. Dennis Moledina, Hannah Melchinger, and Frida Calderon provide a summary of their article "Urine Uromodulin as a Biomarker of Kidney Tubulointerstitial Fibrosis," on behalf of their colleagues.American Society of Nephrology による

1
MR Study of FGF23 and Heart Failure 5:28

2+ y ago5:28

5:28

Dr. Cassianne Robinson-Cohen and Dr. Elvis Akwo discuss findings from their study, "Association of Genetically Predicted Fibroblast Growth Factor-23 with Heart Failure" on behalf of their colleagues.American Society of Nephrology による

聞く価値のあるポッドキャスト

ポッドキャスト American Society Of Nephrology

聞く価値のあるポッドキャスト

クイックリファレンスガイド